CHASERR and colonic neoplasm: To elucidate whether the activation of NF‐κB mediated the oncogenic roles of LINC01578 in colon cancer, DLD‐1 cells with LINC01578 overexpression or control were treated with NF‐κB inhibitor JSH‐23.